Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 31 January, 2012

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 5244W
GlaxoSmithKline PLC
31 January 2012



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in interests of the under-mentioned Person Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc ("Ordinary shares"):


Dr P J T Vallance

Following the vesting on 29 January 2012 of 25% of an award made on 29 January 2007 under the GlaxoSmithKline Deferred Investment Award Plan ("The Plan"), Dr Vallance will receive a cash payment of 1433.25p per share in respect of 4703.976 notional Ordinary shares on 20 February 2012.

The Company and the above-mentioned person were advised of this information by the Administrators of the Plan on 31 January 2012.


This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).



V A Whyte

Company Secretary


31 January 2012


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t